Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study


  • Kristian Karlović Faculty of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina
  • Jadranka Nikolić Faculty of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
  • Jurica Arapović Faculty of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina




Urinary tract infection, ceftriaxone, aminoglycosides, co-amoxiclav, re-infection, Enterococcus spp.


A frequent complication during hospital stay of patients with urinary tract infections (UTIs) is a re-infection of the urinary tract after the initial improvement. In this study, we investigated the impact of two empirical antibiotic therapies on the outcomes of complicated bacterial UTIs. We retrospectively evaluated 325 adult patients hospitalized during 6 years period with a diagnosis of complicated bacterial UTIs. The patients were classified into two groups according to the antibiotic therapy: ceftriaxone- and co-amoxiclav+gentamicin-treated group. Clinical data were collected from the patient records into a designed form. Output data included information on the treatment outcome, length of stay (LOS), development of complications, and cause of re-infections. The patients treated with ceftriaxone had significantly longer LOS (p = 0.012), as well as higher occurrence of complications (p = 0.023) and urinary tract re-infections (p < 0.001), compared to co-amoxiclav+gentamicin-treated group. No significant difference was observed in the treatment outcome between the two groups (p = 0.137). The most common complication in both investigated groups were re-infections of the urinary tract, and Enterococcus spp. was detected as the cause of re-infections only in patients from ceftriaxone-treated group (40/69 patients). Out of the 40 ceftriaxone-treated patients with enterococcal urinary tract re-infections, 35 patients had one or more chronic diseases and 29 patients had urinary catheter inserted. Ceftriaxone therapy should be considered carefully in patients with complicated UTIs due to the possibility of enterococcal re-infection and consequent prolonged hospital stay.



Download data is not yet available.

Author Biographies

  • Jadranka Nikolić, Faculty of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
    Department of Infectious Diseases
  • Jurica Arapović, Faculty of Medicine, University of Mostar, Mostar, Bosnia and Herzegovina Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina
    Department of Infectious Diseases


American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol 2008;111(3):785-94. https://doi.org/10.1097/AOG.0b013e318169f6ef.

Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: Systematic review and meta-analysis. Lancet 2011;377(9761):228-41.


Gardner A, Mitchell B, Beckingham W, Fasugba O. A point prevalence cross-sectional study of healthcare-associated urinary tract infections in six Australian hospitals. BMJ Open 2014;4(7):e005099. https://doi.org/10.1136/bmjopen-2014-005099.

Ackermann RJ, Monroe PW. Bacteremic urinary tract infection in older people. J Am Geriatr Soc 1996;44(8):927-33. https://doi.org/10.1111/j.1532-5415.1996.tb01862.x.

Deulofeu F, Cervello B, Capell S, Marti C, Mercade V. Predictors of mortality in patients with bacteremia: The importance of functional status. J Am Geriatr Soc 1998;46(1):14-8. https://doi.org/10.1111/j.1532-5415.1998.tb01007.x.

Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med 2002;113(Suppl 1A):5S-13S.


Jackson SL, Boyko EJ, Scholes D, Abraham L, Gupta K, Fihn SD. Predictors of urinary tract infection after menopause: A prospective study. Am J Med 2004;117(12):903-11. https://doi.org/10.1016/j.amjmed.2004.07.045.

Jackson SL, Scholes D, Boyko EJ, Abraham L, Fihn SD. Urinary incontinence and diabetes in postmenopausal women. Diabetes Care 2005;28(7):1730-8. https://doi.org/10.2337/diacare.28.7.1730.

Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ. Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care 2002;17(1):50-7. https://doi.org/10.1053/jcrc.2002.33029.

Leuck AM, Wright D, Ellingson L, Kraemer L, Kuskowski MA, Johnson JR. Complications of Foley catheters - Is infection the greatest risk? J Urol 2012;187(5):1662-6. https://doi.org/10.1016/j.juro.2011.12.113.

Litza JA, Brill JR. Urinary tract infections. Prim Care 2010;37(3):491-507, viii. https://doi.org/10.1016/j.pop.2010.04.001.

Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis 2016;29(1):73-9. https://doi.org/10.1097/QCO.0000000000000228.

Skerk V, Andrasevic AT, Andrasevic S, Susic E, Dzepina AM, Madaric V, et al. ISKRA guidelines on antimicrobial treatment and prophylaxis of urinary tract infections - Croatian national guidelines. [Article in Croatian]. Lijec Vjesn 2009;131(5-6):105-18.

Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15(Suppl 1):S216-27. https://doi.org/10.1093/clind/15.Supplement_1.S216.

Khasawneh FA, Karim A, Mahmood T, Ahmed S, Jaffri SF, Tate ME, et al. Antibiotic de-escalation in bacteremic urinary tract infections: Potential opportunities and effect on outcome. Infection 2014;42(5):829-34. https://doi.org/10.1007/s15010-014-0639-8.

Barnes AI, Herrero IL, Albesa I. New aspect of the synergistic antibacterial action of ampicillin and gentamicin. Int J Antimicrob Agents 2005;26(2):146-51. https://doi.org/10.1016/j.ijantimicag.2005.04.014.

Prins JM, Buller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993;341(8841):335-9. https://doi.org/10.1016/0140-6736(93)90137-6.

Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 1996;40(11):2494-9.

Wu YR, Rego LL, Christie AL, Lavelle RS, Alhalabi F, Zimmern PE. Recurrent urinary tract infections due to bacterial persistence or reinfection in women - Does this factor impact upper tract imaging findings? J Urol 2016;196(2):422-8. https://doi.org/10.1016/j.juro.2016.01.111.

Chin BS, Kim MS, Han SH, Shin SY, Choi HK, Chae YT, et al. Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection (UTI) patients. Arch Gerontol Geriatr 2011;52(1):e50-5. https://doi.org/10.1016/j.archger.2010.05.011.

Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect 2005;50(4):296-305. https://doi.org/10.1016/j.jinf.2004.04.004.

Cornia PB, Takahashi TA, Lipsky BA. The microbiology of bacteriuria in men: A 5-year study at a Veterans' Affairs hospital. Diagn Microbiol Infect Dis 2006;56(1):25-30. https://doi.org/10.1016/j.diagmicrobio.2006.03.008.

Vemuri RK, Zervos MJ. Enterococcal infections. The increasing threat of nosocomial spread and drug resistance. Postgrad Med 1993;93(3):121-4, 7-8.

Lloyd S, Zervos M, Mahayni R, Lundstrom T. Risk factors for enterococcal urinary tract infection and colonization in a rehabilitation facility. Am J Infect Control 1998;26(1):35-9. https://doi.org/10.1016/S0196-6553(98)70059-8.

Pallares R, Pujol M, Pena C, Ariza J, Martin R, Gudiol F. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med 1993;153(13):1581-6. https://doi.org/10.1001/archinte.1993.00410130103010.

Magnussen CR, Cave J. Nosocomial enterococcal infections: Association with use of third-generation cephalosporin antibiotics. Am J Infect Control 1988;16(6):241-5. https://doi.org/10.1016/S0196-6553(88)80002-6.

Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model. Clin Infect Dis 1997;24(6):1068-78. https://doi.org/10.1086/513640.

Tseng CC, Wu JJ, Liu HL, Sung JM, Huang JJ. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli. Am J Kidney Dis 2002;39(4):744-52. https://doi.org/10.1053/ajkd.2002.32992.

Lark RL, Saint S, Chenoweth C, Zemencuk JK, Lipsky BA, Plorde JJ. Four-year prospective evaluation of community-acquired bacteremia: Epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2001;41(1-2):15-22. https://doi.org/10.1016/S0732-8893(01)00284-X.

Gokula RR, Hickner JA, Smith MA. Inappropriate use of urinary catheters in elderly patients at a midwestern community teaching hospital. Am J Infect Control 2004;32(4):196-9. https://doi.org/10.1016/j.ajic.2003.08.007.

Fakih MG, Shemes SP, Pena ME, Dyc N, Rey JE, Szpunar SM, et al. Urinary catheters in the emergency department: Very elderly women are at high risk for unnecessary utilization. Am J Infect Control 2010;38(9):683-8. https://doi.org/10.1016/j.ajic.2010.04.219.

Ouslander JG, Griffiths P, McConnell E, Riolo L, Schnelle J. Functional Incidental Training: Applicability and feasibility in the Veterans Affairs nursing home patient population. J Am Med Dir Assoc 2005;6(2):121-7. https://doi.org/10.1016/j.jamda.2005.01.004.

van Houten P, Achterberg W, Ribbe M. Urinary incontinence in disabled elderly women: A randomized clinical trial on the effect of training mobility and toileting skills to achieve independent toileting. Gerontology 2007;53(4):205-10. https://doi.org/10.1159/000100544.

Sugimura T, Arnold E, English S, Moore J. Chronic suprapubic catheterization in the management of patients with spinal cord injuries: Analysis of upper and lower urinary tract complications. BJU Int 2008;101(11):1396-400.


Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991;91(3B):86S-9S. https://doi.org/10.1016/0002-9343(91)90349-3.

Morrison AJ Jr., Wenzel RP. Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital. Arch Intern Med 1986;146(8):1549-51. https://doi.org/10.1001/archinte.1986.00360200111018.

Adesida SA, Ezenta CC, Adagbada AO, Aladesokan AA, Coker AO. Carriage of multidrug resistant Enterococcus Faecium and Enterococcus Faecalis among apparently healthy humans. Afr J Infect Dis 2017;11(2):83-9. https://doi.org/10.21010/ajid.v11i2.11.

Pinholt M, Ostergaard C, Arpi M, Bruun NE, Schonheyder HC, Gradel KO, et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: A population-based cohort study. Clin Microbiol Infect 2014;20(2):145-51. https://doi.org/10.1111/1469-0691.12236.

Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115(8):585-90. https://doi.org/10.7326/0003-4819-115-8-585.

Choi SH, Lee JE, Park SJ, Choi SH, Lee SO, Jeong JY, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: Implications for antibiotic use. Antimicrob Agents Chemother 2008;52(3):995-1000. https://doi.org/10.1128/AAC.01083-07.

Billington EO, Phang SH, Gregson DB, Pitout JD, Ross T, Church DL, et al. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: A population-based study. Int J Infect Dis 2014;26:76-82. https://doi.org/10.1016/j.ijid.2014.02.012.

McBride SJ, Upton A, Roberts SA. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia - A five-year retrospective review. Eur J Clin Microbiol Infect Dis 2010;29(1):107-14. https://doi.org/10.1007/s10096-009-0830-5.

Vigani AG, Oliveira AM, Bratfich OJ, Stucchi RS, Moretti ML. Clinical, epidemiological, and microbiological characteristics of bacteremia caused by high-level gentamicin-resistant Enterococcus faecalis. Braz J Med Biol Res 2008;41(10):890-5. https://doi.org/10.1590/S0100-879X2008001000010.

Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H, et al. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care - Prevalence and risk factors. Int J Med Microbiol 2013;303(8):405-9. https://doi.org/10.1016/j.ijmm.2013.05.002.

Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 2001;7(2):342-7. https://doi.org/10.3201/eid0702.010240.

Keten D, Aktas F, Guzel Tunccan O, Dizbay M, Kalkanci A, Biter G, et al. Catheter-associated urinary tract infections in intensive care units at a university hospital in Turkey. Bosn J Basic Med Sci 2014;14(4):227-33. https://doi.org/10.17305/bjbms.2014.4.140.

Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study


Additional Files





Translational and Clinical Research


How to Cite

Ceftriaxone treatment of complicated urinary tract infections as a risk factor for enterococcal re-infection and prolonged hospitalization: A 6-year retrospective study. Biomol Biomed [Internet]. 2018 Nov. 7 [cited 2024 Jul. 23];18(4):361-6. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/3544